Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Perceptive Advisors
company
About
Perceptive Advisors is a privately owned hedge fund sponsor that finances the public equity markets across the globe.
- 11 - 50
Highlights
Details
- Industries
- Finance,Financial Services,Venture Capital
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Hedge Fund,MVC
Perceptive Advisors, LLC is a privately owned hedge fund sponsor. The firm invests in the public equity markets across the globe. It employs a long/short equity strategy as a hedging technique while making its investments. The firm typically invests in biotechnology and life sciences sectors to make its investments. Perceptive Advisors is based in New York, New York.
Investments
Number of Investments
Number of Lead Investments
44
19
Perceptive Advisors has made 44 investments. Their most recent investment was on
Dec 7, 2022, when Apogee Therapeutics raised $149M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 7, 2022
Apogee Therapeutics
|
Series B | $149M | Biotechnology | — |
|
Nov 16, 2022
Biodesix
|
Post-IPO Debt | $50M | Biotechnology | Yes |
|
Apr 12, 2022
Surf Bio
|
Seed | $16M | Biotechnology | Yes |
|
Mar 8, 2022
DNAnexus
|
Series H | $200M | Bioinformatics | — |
|
Dec 7, 2021
Freenome
|
Series D | $300M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
